FactSet Announces Investor Day 2024
NORWALK, Conn., Sept. 16, 2024 (GLOBE NEWSWIRE) — FactSet (NYSE: FDS | NASDAQ: FDS), a global financial digital platform and enterprise […]
Trailbreaker Defines a 10 Km Copper-In-Soil Anomaly and Assays 23.71% Copper in Rock Sample at Liberty Property
VANCOUVER, British Columbia, Sept. 16, 2024 (GLOBE NEWSWIRE) — Trailbreaker Resources Ltd. (TBK.V) (“Trailbreaker” or “the Company”) is pleased to […]
Checkpoint Therapeutics Announces Cosibelimab Longer-Term Results in Advanced Cutaneous Squamous Cell Carcinoma Presented at ESMO Congress 2024
WALTHAM, Mass., Sept. 16, 2024 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology […]
TSX News -
Mattr Signs Definitive Agreement to Sell Its Brazilian Pipe Coating Business to Vallourec For US$17.5M
TORONTO, Sept. 16, 2024 (GLOBE NEWSWIRE) — Mattr Corp. (“Mattr” or the “Company”) (TSX: MATR) announced today that it has […]
Bread Financial™ Provides Performance Update for August 2024
COLUMBUS, Ohio, Sept. 16, 2024 (GLOBE NEWSWIRE) — Bread Financial Holdings, Inc. (NYSE: BFH), a tech-forward financial services company that […]
FTI Consulting Launches National Security Offering Led by Former FBI Assistant Director
WASHINGTON, Sept. 16, 2024 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the launch of a National Security […]
Tintina Mines Limited Announces 2024 Exploration Plan for the Domeyko Sulfuros Project
TORONTO, Sept. 16, 2024 (GLOBE NEWSWIRE) — Tintina Mines Limited (“Tintina” or the “Company”) (TSX: TTS) is pleased to announce […]
TSX News -
Aya Gold & Silver Extends Boumadine Main Zone to 5.4km and Reports High-Grade Drill Results
MONTREAL, Sept. 16, 2024 (GLOBE NEWSWIRE) — Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) […]
Churchill Resources Starts Drill Program and Enters into Option Agreement to Acquire Properties at Taylor Brook, Newfoundland
TORONTO, Sept. 16, 2024 (GLOBE NEWSWIRE) — Churchill Resources Inc. (“Churchill” or the “Company“) (TSXV: CRI) is pleased to announce […]
Can-Fite: Pancreatic Carcinoma Phase IIa Clinical Study with Namodenoson Received Regulatory Authorization from the Israeli Ministry of Health
Study will aim to establish safety and clinical efficacy PETACH TIKVA, Israel, Sept. 16, 2024 (GLOBE NEWSWIRE) — Can-Fite BioPharma […]
